SB

Sunita Barnwal

Active Director Director DIN 08957482
DIN 08957482 First appointment Nov 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Sunita Barnwal

Data last updated:

Sunita Barnwal is a Director at Astragenex Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Astragenex Pharmaceuticals Private Limited reported revenue of ₹25.7 Lakh (FY 2022).

DIN 08957482
Primary Designation Director
Industry Chemicals
First Appointment 11 Nov 2020
Oldest Company Age 6 yrs
Largest company Astragenex Pharmaceuticals Private Limited · ₹25.7 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Nov 20202020₹25.7 Lakh (FY 2022)Active

Directorship timeline

Open interactive timeline →
Astragenex Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sunita Barnwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunita Barnwal

Sunita Barnwal currently holds 1 directorship: Astragenex Pharmaceuticals Private Limited (Director, since 11 Nov 2020, revenue ₹25.7 Lakh (FY 2022)).

Sunita Barnwal was first appointed on 11 Nov 2020 as Director at Astragenex Pharmaceuticals Private Limited.

The current boards of Sunita Barnwal's companies include Poonam Verma (Astragenex Pharmaceuticals Private Limited), Shambhu Nath Keshri (Astragenex Pharmaceuticals Private Limited), Sweta Sinha (Astragenex Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available